Adaptimmune Therapeutics PLC
F:473A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Adaptimmune Therapeutics PLC
F:473A
|
UK |
|
G
|
Global Food and Ingredients Ltd
XTSX:PEAS
|
CA |
|
AC Partners Inc
OTC:ACPS
|
US |
|
First United Corp
NASDAQ:FUNC
|
US |
|
P
|
Pilkington Deutschland AG
F:FDD
|
DE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 473A's stock price target?
Not Available
473A does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Adaptimmune Therapeutics PLC?
Projected CAGR
9%
Over the last 11 years, the compound annual growth rate for Revenue has been 68%. The projected CAGR for the next 4 years is 9%.